Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda ...

Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply agreement with ...

Palisade Bio, Inc. (($PALI)) announced an update on their ongoing clinical study. Study Overview: Palisade Bio, Inc. has completed a Phase 1 ...

How do you treat ulcerative colitis? Treatment typically involves medications to suppress inflammation, control symptoms and reduce complications. "We have made great strides in the last 15 or 20 ...

Future perspectives in ulcerative colitis research Ongoing research into ulcerative colitis continues to uncover new treatment options, therapies, and ways to improve patient outcomes.

Ulcerative colitis affects over 900,000 Americans and is a form of inflammatory bowel disease (IBD). The exact causes of the illness remain unknown, but ulcerative colitis can be disabling ...

Ulcerative colitis is the most common cause of proctitis, but it's not the only cause. You can get proctitis from a STD or other infection, medicine, radiation therapy, or bowel surgery.

Ulcerative colitis treatment The range of medications for UC includes anti-inflammatory drugs such as corticosteroids, immune system suppressors and biologics that target proteins made by the ...

The study, which involved more than 600 people with ulcerative colitis between ages 10 and 24, also found that a quarter discontinued their treatment after just one month.